- Release Date: 29/04/22 19:10
- Summary: Quarterly Activities/Appendix 5B Cash Flow Report
- Price Sensitive: Yes
- Download Document 462.12KB
- Forums
- ASX - By Stock
- NC1
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NC1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.72M |
Open | High | Low | Value | Volume |
9.8¢ | 9.8¢ | 9.8¢ | $94 | 964 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 21968 | 9.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 30000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 21968 | 0.098 |
2 | 111052 | 0.096 |
3 | 256807 | 0.095 |
1 | 5466 | 0.090 |
1 | 19900 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 30000 | 1 |
0.120 | 10000 | 1 |
0.125 | 4999 | 1 |
0.130 | 10000 | 1 |
0.140 | 49869 | 2 |
Last trade - 10.06am 24/09/2024 (20 minute delay) ? |
Featured News
NC1 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online